FSHR: Target/Biomarker Introduction, products summarized (antibody/ADC/bispecific/antigen/ORF vector/VLP) and disease/indication/condition/MOA for drug discovery and IVD

It’s the GeneMedi’s summary page for Target/Biomarker Introduction of FSHR. The page also collects GeneMedi’s different modalities and formats products for FSHR in therapeutics/drug discovery and IVD diagnostics, which is including antibody, ADC, bispecific, antigen, ORF vector, VLP, etc. With GeneMedi’s target-insight database-GM ITD database, the FSHR target is also connected to human indications/diseases/conditions/MOA.

Target sublocation: Transmembrane Protein.

The protein encoded by this gene belongs to family 1 of G-protein coupled receptors. It is the receptor for follicle stimulating hormone and functions in gonad development. Mutations in this gene cause ovarian dysgenesis type 1, and also ovarian hyperstimulation syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]

Target ID
GM-T68334

Target Name
FSHR

Gene ID
2492

Gene Official Name
FSHR

Gene Alias
FSHR1O, LGR1, ODG1, FSHR

Protein Sub-location
Transmembrane Protein

Category
Therapeutics Target, Immuno-oncology Target, INN Index

Pre-made FSHR-specific INN-index biosimilar (antibody&conjugates)-corifollitropin alfa

Anti-FSHR therapeutic INN-index antibodies and conjugates are biosimilars expressed by mammalian cell line as a benchmark reference therapeutic antibody for drug discovery, target MOA research, cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Filters Sort results
Reset Apply
Cat No.
Products Name (INN Index)
INN Name
Previous Name
Target
Format
Order
GMP-Bios-INN-788
Pre-Made Corifollitropin Alfa Biosimilar, Fusion Protein targeting FSHR fused with CTP (C-terminal peptide of hCG): Recombinant therapeutic protein targeting FSHRO/LGR1/ODG1
corifollitropin alfa
NA
FSHR
Fusion Protein

Anti-FSHR/ FSHR1O/ LGR1 antibody for FACS & in-vivo assay| GMab

Pre-made anti-FSHR benchmark inhibitory monoclonal antibody(mab, blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). The anti-FSHR mab is expressed and produced by mammalian cell line as a benchmark reference therapeutic antibody for biological drug discovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Filters Sort results
Reset Apply
Cat No.
Antibody Name
Format
Classified by tag
Order
GM-Tg-hg-T68334-Ab
Anti-FSHR monoclonal antibody
mab
FACS/Biofunctional Antibody, Therapeutics Target antibody